Figure 1.
Time to disease progression, relapse or death after a median follow-up of 30 months among 321 patients assigned to chemotherapy with CVP or with R-CVP. Solid line represents CVP; dotted line, R-CVP.
Time to disease progression, relapse or death after a median follow-up of 30 months among 321 patients assigned to chemotherapy with CVP or with R-CVP. Solid line represents CVP; dotted line, R-CVP.
